INSUBCONTINENT EXCLUSIVE:
cent lower, likely pointing to easing concerns over an import alert after a US regulatory report on a key plant of the drugmaker.
The stock
ended the day at Rs 2,563.35 apiece after plunging in early trade
suboxone.
But the stock is trading at 20 times FY20 estimated earnings, implying full multiples to the limited time earnings, it
